AstraZeneca (AZN) News Today → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free AZN Stock Alerts $76.90 -0.14 (-0.18%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 17 at 7:48 PM | seekingalpha.comPuma Biotech pares gain amid Wyeth victory in Tagrisso patent case against AstraZenecaMay 17 at 5:41 PM | reuters.comPfizer wins $107.5 million from AstraZeneca in US cancer drug patent trialMay 17 at 9:29 AM | marketbeat.comJanney Montgomery Scott LLC Grows Stake in AstraZeneca PLC (NASDAQ:AZN)Janney Montgomery Scott LLC lifted its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 23.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 261,743 shares of the company's stock after purchasing an additional 49,252 shMay 17 at 2:34 AM | americanbankingnews.comAstraZeneca PLC (NASDAQ:AZN) to Post Q2 2024 Earnings of $0.91 Per Share, Zacks Research ForecastsMay 16 at 7:51 AM | marketbeat.comEquities Analysts Offer Predictions for AstraZeneca PLC's Q2 2024 Earnings (NASDAQ:AZN)AstraZeneca PLC (NASDAQ:AZN - Free Report) - Research analysts at Zacks Research reduced their Q2 2024 earnings per share estimates for AstraZeneca in a report released on Wednesday, May 15th. Zacks Research analyst R. Department now anticipates that the company will earn $0.91 per share for theMay 16 at 6:10 AM | investorplace.com7 Blue-Chip Stocks to Protect Your Wealth as the Economy SlowsMay 16 at 3:48 AM | markets.businessinsider.comAZN:Phase III Trial Of Sipavibart Met Main Goal In Preventing COVID-19 In Immunocompromised PatientsMay 16 at 2:17 AM | reuters.comAstraZeneca's investigational COVID drug meets primary goals in late-stage studyMay 16 at 1:58 AM | americanbankingnews.comAstraZeneca PLC (NASDAQ:AZN) Receives Average Recommendation of "Moderate Buy" from BrokeragesMay 16 at 1:57 AM | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Receives Average Rating of "Moderate Buy" from AnalystsAstraZeneca PLC (NASDAQ:AZN - Get Free Report) has been given a consensus rating of "Moderate Buy" by the seven brokerages that are currently covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and four have given a buy recommendaMay 14 at 9:07 PM | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by Thornburg Investment Management Inc.Thornburg Investment Management Inc. cut its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 11.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 508,872 shares of the company's stock after selling 63,208 sharesMay 14 at 12:33 PM | marketbeat.comAstraZeneca (NASDAQ:AZN) Hits New 1-Year High at $77.93AstraZeneca (NASDAQ:AZN) Hits New 52-Week High at $77.93May 13, 2024 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Acquired by Envestnet Portfolio Solutions Inc.Envestnet Portfolio Solutions Inc. raised its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 13.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 115,428 shares of the company's stock after purchasingMay 13, 2024 | msn.comHealthcare Giants Pfizer, AstraZeneca, Sanofi Inject Over $2B To Boost France's Healthcare SectorMay 12, 2024 | msn.comIf I’d invested £10k in AstraZeneca shares three months ago here’s what I’d have nowMay 12, 2024 | reuters.comPfizer and AstraZeneca announce new investments of nearly $1 billion in FranceMay 12, 2024 | fool.comForget Johnson & Johnson: Buy This Better Healthcare Stock InsteadMay 11, 2024 | marketbeat.comAGF Management Ltd. Purchases 11,419 Shares of AstraZeneca PLC (NASDAQ:AZN)AGF Management Ltd. grew its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 1.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 797,030 shares of the company's stock after purchasing an adMay 9, 2024 | msn.comJUST IN: COVID-19 vaccine withdrawn by producer due to dangerous side effects - Tribune OnlineMay 9, 2024 | msn.comWas COVID Vaccine Recalled Over Health Danger Fears? What We KnowMay 8, 2024 | marketbeat.comAstraZeneca (NASDAQ:AZN) Sets New 12-Month High at $77.16AstraZeneca (NASDAQ:AZN) Hits New 52-Week High at $77.16May 8, 2024 | msn.comAstraZeneca withdraws COVID-19 vaccineMay 8, 2024 | msn.comAstraZeneca to withdraw COVID vaccine globally as demand dipsMay 8, 2024 | msn.comUK Stocks: AstraZeneca (AZN) to Withdraw COVID Vaccine as Demand WanesMay 8, 2024 | msn.comAstraZeneca is withdrawing COVID shot worldwide due to vaccine glutMay 8, 2024 | msn.comAstraZeneca Pulls Plug On Vaxzevria COVID-19 Vaccine Amid Surplus of Updated VaccinesMay 8, 2024 | msn.comAstraZeneca lifts FTSE 100 to record high; BOE rate decision on tapMay 7, 2024 | marketbeat.comEverpar Advisors LLC Acquires Shares of 11,018 AstraZeneca PLC (NASDAQ:AZN)Everpar Advisors LLC acquired a new stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 11,018 shares of the company's stock, valued at approxMay 7, 2024 | reuters.comAstraZeneca to withdraw Covid vaccine worldwide, The Telegraph reportsMay 7, 2024 | cnbc.comAmgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominanceMay 6, 2024 | businesswire.comInocras Hong Kong Limited, in Collaboration with Cancerinformation.com.hk Charity Foundation and Sponsored by AstraZeneca Hong Kong, Offers Free BRCA or HRD Genetic Testing for Eligible Cancer Patients in Hong Kong and MacauMay 6, 2024 | msn.comAstraZeneca invests $140M in Cellectis, raising stake to 44%May 6, 2024 | msn.comAstraZeneca invests $140M in Cellectis, raising stake to 44%May 6, 2024 | marketbeat.comNational Bank of Canada FI Has $35.03 Million Stake in AstraZeneca PLC (NASDAQ:AZN)National Bank of Canada FI lessened its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 36.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 512,196 shares of the company's stock after sellingMay 6, 2024 | finance.yahoo.comCellectis Announces Completion of the Additional Equity Investment by AstraZenecaMay 5, 2024 | marketbeat.comTodd Asset Management LLC Purchases 80,148 Shares of AstraZeneca PLC (NASDAQ:AZN)Todd Asset Management LLC increased its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 19.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 489,310 shares of the company's stock afterMay 4, 2024 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Position Boosted by Raymond James Financial Services Advisors Inc.Raymond James Financial Services Advisors Inc. boosted its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 8.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 176,162 shares of the company's stoMay 4, 2024 | finance.yahoo.comAstraZeneca PLC (AZN)May 3, 2024 | marketbeat.comNatixis Advisors L.P. Grows Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)Natixis Advisors L.P. grew its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 6.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,250,618 shares of the company's stock after purchasMay 3, 2024 | marketbeat.comWesbanco Bank Inc. Buys New Stake in AstraZeneca PLC (NASDAQ:AZN)Wesbanco Bank Inc. purchased a new stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 73,983 shares of the company's stock, valued at approximaMay 2, 2024 | businesswire.comCALQUENCE combination regimen demonstrated statistically significant and clinically meaningful improvement in progression-free survival in 1st-line mantle cell lymphoma in ECHO Phase III trialMay 1, 2024 | marketbeat.comHowe & Rusling Inc. Has $10.54 Million Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)Howe & Rusling Inc. boosted its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 22.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 156,496 shares of the company's stock after acquiring an additional 28,May 1, 2024 | baystreet.caAstraZeneca Jumps Ahead of Showing New DataMay 1, 2024 | baystreet.caAstraZeneca Jumps Ahead of Showing New DataApril 30, 2024 | finance.yahoo.comAstraZeneca PLC (NASDAQ:AZN) Q1 2024 Earnings Call TranscriptApril 30, 2024 | marketbeat.comAtria Wealth Solutions Inc. Increases Holdings in AstraZeneca PLC (NASDAQ:AZN)Atria Wealth Solutions Inc. boosted its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 47.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 33,101 shares of the company's stock after purchasing an adApril 29, 2024 | benzinga.comAstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very Rare Case, But Causal Mechanism UnknownApril 29, 2024 | finance.yahoo.comAstraZeneca’s Fasenra: Approval for asthma may initiate COPD approvalApril 29, 2024 | markets.businessinsider.comUK Stocks: AstraZeneca (AZN) Shares Rise on Promising Breast Cancer Drug UpdatesApril 29, 2024 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Short Interest UpdateAstraZeneca PLC (NASDAQ:AZN - Get Free Report) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 8,580,000 shares, an increase of 12.0% from the March 31st total of 7,660,000 shares. Based on an average daily volume of 6,160,000 shares, the days-to-cover ratio is presently 1.4 days. Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. AZN Media Mentions By Week AZN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZN News Sentiment▼0.720.54▲Average Medical News Sentiment AZN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZN Articles This Week▼2015▲AZN Articles Average Week Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Novartis News AbbVie News Abbott Laboratories News Pfizer News Merck & Co., Inc. News Sanofi News Johnson & Johnson News Regeneron Pharmaceuticals News Vertex Pharmaceuticals News GSK News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AZN) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressThe Next Industry Being Reshaped By AIThe Bull ReportWhy Is Gold On a MASSIVE rally? Huge AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceUrgent Nvidia WarningAltimetryMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
